Stay Informed About New Multiple Sclerosis Meds
June 2021
Kesimpta and Zeposia will add to the growing list of meds to treat relapsing-remitting multiple sclerosis (MS).
Expect most of these patients to start treatment right away...to reduce flares and slow progression.
We're used to seeing the traditional injectables (Avonex, Copaxone, etc) first-line...while some patients prefer an oral med (Aubagio, Gilenya, etc) or don't tolerate injectables.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive